Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 49

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 49
---
 at Vesting of Stock Awards and Option Awards Granted in Fiscal Year That Vested During 2024                                                                     |     | -e |     | $    |          — |
| + |     | Change in Fair Value as of Vesting Date of Stock Awards and Option Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During 2024 |     | -f |     | $    |  3,507,346 |
| - |     | Fair Value as of 2023 Fiscal Year End of Stock Awards and Option Awards Granted in Prior Fiscal years That Failed to Meet Applicable Vesting Conditions During 2024        |     | -g |     | $    |          — |
| = |     | Compensation Actually Paid                                                                                                                                                 |     |    |     | $    | 23,086,469 |

__________________________

(a) Represents Total Compensation as reported in the Summary Compensation Table for the indicated 2024.

(b) Represents the aggregate grant date fair value of the stock awards and option awards granted to the PEO during 2024, computed in accordance with FASB ASC 718, as reported in the Summary Compensation Table for the indicated fiscal year.

(c) Represents the aggregate fair value as of the 2024 year-end of the PEO's outstanding and unvested stock awards and option awards granted during 2024, computed in accordance with FASB ASC 718.

(d) Represents the aggregate change in fair value during 2024 of the outstanding and unvested stock awards and option awards held by the PEO as of the last day of 2024, computed in accordance with FASB ASC 718 and, for awards subject to performance-based vesting conditions, as of 2024 fiscal year end, based on the probable outcome of such performance-based vesting conditions as of the last day of

<div align='center'>35</div>

2024, and for performance-based awards with performance periods ending on in 2024, based on actual attainment as of the end of the applicable performance period.

(e) Represents the aggregate fair value at vesting of the stock awards and option awards that were granted to the PEO and vested during 2024, computed in accordance with FASB ASC 718.

(f) Represents the aggregate change in fair value, measured from 2023 fiscal year-end to the vesting date, of each stock award and option award held by the PEO that was granted in a prior fiscal year and which